转变疫苗学
Rino Rappuoli1, Galit Alter2, Bali Pulendran3
1Biotecnopolo di Siena Foundation, Siena, Italy.
Cell
|September 20, 2024
概括
疫苗研发在两个世纪中取得了显著的进步,最近的mRNA技术和系统免疫学等创新改变了公共卫生. 未来的疫苗旨在增强对传染病的持久免疫反应.
科学领域:
- 疫苗学和免疫学
- 公共卫生
- 生物技术
背景情况:
- COVID-19 疫情凸显了疫苗在公共卫生中的关键作用.
- 2023年诺贝尔奖认可mRNA疫苗的开发,强调了最近的进展.
- 疫苗研发有两个世纪的丰富历史.
研究的目的:
- 提供疫苗开发创新的历史概述.
- 讨论最近技术进步改变了疫苗学.
- 探索系统免疫学在理解和改善疫苗反应中的作用.
主要方法:
- 两个世纪以来疫苗开发的历史视角.
- 技术革命的回顾:逆向疫苗学,合成生物学,基于结构的设计.
- 突出了mRNA疫苗,新型辅助剂和系统免疫学的进展.
主要成果:
- 针对具有挑战性的病原体,如B血清组Neisseria meningitidis和呼吸道同胞病毒 (RSV) 研制成功的疫苗.
- mRNA疫苗技术提供了速度和灵活性,显著改变了开发模式.
- 新的辅助剂和系统免疫学方法有望增强和调整免疫反应.
结论:
- 技术创新已经克服了疫苗开发的历史挑战.
- mRNA技术和系统免疫学在疫苗学方面取得了重大进展.
- 未来的研究重点是了解和刺激人类对疫苗的持久免疫反应.
相关概念视频
Vaccinations
44.1K
Overview
44.1K
Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345


